Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Fenofibrate Capsules, USP 43 Mg And 130 Mg
4/23/2014 7:48:20 AM
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Fenofibrate Capsules, USP 43 mg and 130 mg a therapeutic equivalent generic version of ANTARA® (fenofibrate) capsules, in the US market on April 22, 2014, approved by the United States Food & Drug Administration (USFDA).
Help employers find you! Check out all the jobs and post your resume.
comments powered by